Bausch & Lomb BLCO
NYSE BLCO
$17.24 +0.04 (+0.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch & Lomb (BLCO) Cash from Investing Activities (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Cash from Investing Activities came in at -$87.0 million in Q2 2026, up 3.33% YoY from -$84.2 million in Q2 2025, and up 33.08% on a QoQ basis from -$130.0 million in Q1 2026.

Bausch & Lomb (BLCO) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has 6 years of Cash from Investing Activities data on file, last reported at -$87.0 million in Q2 2026.

  • Quarterly Cash from Investing Activities rose 3.33% year-over-year to -$87.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$466.0 million (up 4.31% YoY) and the FY2025 annual result came in at -$455.0 million, down 10.44% from the prior year.
  • Cash from Investing Activities climbed to -$87.0 million in Q2 2026, from -$130.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$28.0 million in Q2 2023 to a low of -$1.9 billion in Q3 2023.
  • A 5-year average of -$189.3 million and a median of -$88.5 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities sank 3740.82% — and 2024, when it surged 94.9%.
  • Tracing BLCO's Cash from Investing Activities over 5 years: stood at -$90.0 million in 2022, then slumped by 50.0% to -$135.0 million in 2023, then slumped by 37.04% to -$185.0 million in 2024, then decreased by 1.62% to -$188.0 million in 2025, then soared by 53.72% to -$87.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$87.0 million (Q2 2026), -$130.0 million (Q1 2026), and -$188.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -241.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -222.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -383.65 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -461.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -43.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -87.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -90.00 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -117.00 Mn
10 Bausch & Lomb 6.14 Bn 5.76 Bn 867.00 Mn -87.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -87.00 Mn
Jun 30, 2026 -87.00 Mn
Mar 31, 2026 -130.00 Mn
Mar 31, 2026 -130.00 Mn
Dec 31, 2025 -188.00 Mn
Dec 31, 2025 -188.00 Mn
Sep 30, 2025 -61.00 Mn
Sep 30, 2025 -61.00 Mn
Jun 30, 2025 -90.00 Mn
Jun 30, 2025 -90.00 Mn
Mar 31, 2025 -116.00 Mn
Mar 31, 2025 -116.00 Mn
Dec 31, 2024 -185.00 Mn
Dec 31, 2024 -185.00 Mn
Sep 30, 2024 -96.00 Mn
Sep 30, 2024 -96.00 Mn
Jun 30, 2024 -74.00 Mn
Jun 30, 2024 -74.00 Mn
Mar 31, 2024 -57.00 Mn
Mar 31, 2024 -57.00 Mn